Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2Xls
2D Structure
Also known as: 4-aminobenzenesulfonic acid, 121-57-3, Sulphanilic acid, P-aminobenzenesulfonic acid, Aniline-4-sulfonic acid, Aniline-p-sulfonic acid
Molecular Formula
C6H7NO3S
Molecular Weight
173.19  g/mol
InChI Key
HVBSAKJJOYLTQU-UHFFFAOYSA-N
FDA UNII
434Z8C2635

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-aminobenzenesulfonic acid
2.1.2 InChI
InChI=1S/C6H7NO3S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H,8,9,10)
2.1.3 InChI Key
HVBSAKJJOYLTQU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1N)S(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
434Z8C2635
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-aminobenzenesulfonic Acid

2. 4-aminobenzenethiol

3. 4-sulfanilic Acid

4. 4-sulfanilic Acid, Sodium Salt

5. 4-sulfanilic Acid, Zinc (2:1) Salt

6. Para-aminobenzenesulfonic Acid

2.3.2 Depositor-Supplied Synonyms

1. 4-aminobenzenesulfonic Acid

2. 121-57-3

3. Sulphanilic Acid

4. P-aminobenzenesulfonic Acid

5. Aniline-4-sulfonic Acid

6. Aniline-p-sulfonic Acid

7. Sulfanilsaeure

8. Benzenesulfonic Acid, 4-amino-

9. Aniline-p-sulphonic Acid

10. P-aminophenylsulfonic Acid

11. P-anilinesulfonic Acid

12. Kyselina Sulfanilova

13. Chebi:27500

14. 4-sulfoaniline

15. Nsc 7170

16. 4-aminobenzene-1-sulfonic Acid

17. Chembl1566888

18. Nsc-7170

19. Mfcd00007886

20. Benzenesulfonic Acid, 4-amino-, Homopolymer

21. 434z8c2635

22. 71949-32-1

23. Sulfanilsaeure [german]

24. 4-sulfanilic Acid

25. Kyselina Sulfanilova [czech]

26. 129674-17-5

27. Ccris 4576

28. Sufanilic Acid

29. Hsdb 5590

30. 4-aminobenzenesulphonic Acid (sulphanilic Acid)

31. P-sulfanilic Acid

32. Einecs 204-482-5

33. P-sulfoaniline

34. Aniline P-sulfonic Acid

35. Ai3-15414

36. Sulfanilic Acid;

37. P-sulphanilic Acid

38. Unii-434z8c2635

39. 4-aminobenzenesulphonic Acid

40. Sulfanilic Acid, 99%

41. Sulfanilic Acid Anhydrous

42. 4-aminophenylsulfonic Acid

43. Bmse000726

44. Epitope Id:122241

45. Ec 204-482-5

46. P-aminobenzenesulphonic Acid

47. P-aminobenzene Sulfonic Acid

48. 4-aminobenzene-sulfonic Acid

49. Schembl24407

50. Sulfanilic Acid [mi]

51. 4-amino Benzenesulphonic Acid

52. 97675-28-0

53. Sulfanilic Acid, >=99.0%

54. Sulfanilic Acid [hsdb]

55. 1-aminobenzene-4-sulfonic Acid

56. 4-amino-1-benzenesulfonic Acid

57. Sulfanilic Acid, 98%, Tech.

58. Dtxsid6024464

59. Nsc7170

60. Sulfanilic Acid [usp-rs]

61. Zinc1530397

62. Nitrate Reagent B, For Microbiology

63. Bbl011603

64. Bdbm50443531

65. Stk661383

66. Sulfanilic Acid, Acs Reagent, 99%

67. Akos000118732

68. Am91128

69. Ncgc00090886-01

70. Ncgc00090886-02

71. Ac-12565

72. Vs-02984

73. Sulfanilic Acid [for Biochemical Research]

74. Mesalazine Impurity O [ep Impurity]

75. Sulfanilic Acid, P.a., 98.0-102.0%

76. Ft-0674701

77. S0120

78. Sulfadiazine Impurity B [ep Impurity]

79. U0107

80. Sulfadimidine Impurity F [ep Impurity]

81. C06335

82. E80415

83. Sulfadimethoxine Impurity D [ep Impurity]

84. Sulfamethoxazole Impurity D [ep Impurity]

85. Sulfanilic Acid, Vetec(tm) Reagent Grade, 99%

86. Q253746

87. Sulfanilic Acid, Puriss. P.a., >=99.0% (t)

88. J-004536

89. 4-aminobenzenesulfonic Acid 100 Microg/ml In Methanol

90. Sulfanilic Acid, Jis Special Grade, 99.0-100.5%

91. F0001-0346

92. Sulfanilic Acid, United States Pharmacopeia (usp) Reference Standard

93. Sulfadimethoxine Sodium For Veterinary Use Impurity D [ep Impurity]

94. Sulfanilic Acid, 99.0-100.5%, Suitable For Determination Of Nitroxide

95. Benzenesulfonic Acid, 4-amino-, Diazotized, Coupled With Dyer's Mulberry Extract

96. Benzenesulfonic Acid,4-amino-,diazotized,coupled With Dyer's Mulberry Extract

97. Sulfanilic Acid, Pharmaceutical Secondary Standard; Certified Reference Material

98. Benzenesulfonic Acid,4-amino-,diazotized,coupled With 5,5'-oxybis[1,3-benzenediol],sodium Salt

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 173.19 g/mol
Molecular Formula C6H7NO3S
XLogP3-0.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass173.01466426 g/mol
Monoisotopic Mass173.01466426 g/mol
Topological Polar Surface Area88.8 Ų
Heavy Atom Count11
Formal Charge0
Complexity211
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Absorption, Distribution and Excretion

4-Aminobenzene sulfonic acid can be absorbed from the gastrointestinal tract. Absorption through the lungs appears to be possible; absorption of an intratracheally-instilled solution of 4- aminobenzene sulfonic acid has been detected in the rat. Accumulation does not take place in mammals; excretion after oral administration mainly occurs within 24 hr. 4-Aminobenzene sulfonic acid is excreted either unchanged or as the N-acetyl metabolite, in the urine in rabbits, and in the urine and the feces in rats.

Anonymous; Toxikologische Bewertung. Heidelberg, Berufsgenossenschaft der chemischen Industrie 252: 27 (1993)


WHEN SULFANILIC ACID WAS ADMINISTERED ORALLY TO RATS, 53% OF THE ADMINISTERED DOSE WAS FOUND IN THE URINE.

SCHELINE RR, LONGBERG B; THE ABSORPTION, METABOLISM AND EXCRETION OF THE SULFONATED AZO DYE, ACID YELLOW, BY RATS; ACTA PHARMACOL TOXICOL 23(1) (1965)


4.2 Metabolism/Metabolites

YIELDS P-ACETAMIDOBENZENESULFONIC ACID IN RABBIT: DANIEL, JW, TOXICOL APPL PHARMAC, 4, 572 (1962). /FROM TABLE/

Goodwin, B.L. Handbook of Intermediary Metabolism of Aromatic Compounds. New York: Wiley, 1976., p. S-14


4.3 Mechanism of Action

Many idiosyncratic non-steroidal anti-inflammatory drugs (NSAIDs) cause GI, liver and bone marrow toxicity in some patients which results in GI bleeding/ulceration/fulminant hepatic failure/hepatitis or agranulocytosis/aplastic anemia. The toxic mechanisms proposed have been reviewed. Evidence is presented showing that idiosyncratic NSAID drugs form prooxidant radicals when metabolized by peroxidases known to be present in these tissues. Thus GSH, NADH and/or ascorbate were cooxidised by catalytic amounts of NSAIDs and hydrogen peroxide in the presence of peroxidase. During GSH and NADH cooxidation, oxygen uptake and activation occurred. Furthermore the formation of NSAID oxidation products was prevented during the cooxidation indicating that the cooxidation involved redox cycling of the first formed NSAID radical product. The order of prooxidant catalytic effectiveness of fenamate and arylacetic acid NSAIDs was mefenamic acid>tolfenamic acid>flufenamic acid, meclofenamic acid or diclofenac. Diphenylamine, a common moiety to all of these NSAIDs was a more active prooxidant for NADH and ascorbate cooxidation than these NSAIDs which suggests that oxidation of the NSAID diphenylamine moiety to a cation and/or nitroxide radical was responsible for the NSAID prooxidant activity. The order of catalytic effectiveness found for sulfonamide derivatives was sulfaphenazole>sulfisoxazole>dapsone>sulfanilic acid>procainamide>sulfamethoxazole>sulfadiazine>sulfadimethoxine whereas sulfanilamide, sulfapyridine or nimesulide had no prooxidant activity. Although indomethacin had little prooxidant activity, its major in vivo metabolite, N-deschlorobenzoyl indomethacin had significant prooxidant activity. Aminoantipyrine the major in vivo metabolite of aminopyrine or dipyrone was also more prooxidant than the parent drugs. It is hypothesized that the NSAID radicals and/or the resulting oxidative stress initiates the cytotoxic processes leading to idiosyncratic toxicity.

PMID:12399153 Galati G et al; Chem Biol Interact 142 (1-2): 25-41 (2002)